MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer

Colorectal cancer is one of the most common malignancies worldwide. Oxaliplatin is the first-line chemotherapeutic agent for the treatment of advanced colorectal cancer. However, acquired resistance to oxaliplatin limits its therapeutic efficacy, and the underlying mechanism remains largely unclear....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Qian, Xiao-Lan, Zhou, Fang, Xu, Song, Jiang, Jian, Chen, Zhi-Peng, Wang, Shao-Kai, Zuo, Yun, Ni, Chen
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129568/
https://ncbi.nlm.nih.gov/pubmed/34017681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.638537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars